Potential of Iron Oxide Nanoparticles as Drug Delivery Vehicle

dc.contributor.authorHassan, Muhammad Aamir
dc.contributor.authorKhan, Aqib Zafar
dc.contributor.authorSajid, Muhammad Munir
dc.contributor.authorJaved, Yasir
dc.contributor.authorUllah, Asmat
dc.contributor.authorShad, Naveed Akhtar
dc.contributor.authorSharma, Surender K.
dc.contributor.authorShafique, Muhammad
dc.contributor.authorSarwar, Muhammad
dc.date.accessioned2024-01-21T10:42:36Z
dc.date.accessioned2024-08-13T12:44:39Z
dc.date.available2024-01-21T10:42:36Z
dc.date.available2024-08-13T12:44:39Z
dc.date.issued2021-10-29T00:00:00
dc.description.abstractNanotechnology has introduced new techniques and therapeutic approaches for the treatment of different cancer types. Current cancer-curing drugs have many limitations such as use of high concentrations, effects on other cells, and non-confinement at cancer sites, which reduce the efficacy of drugs and also induce toxic effects in other normal cells. Nanomaterials have provided new ways to increase the efficacy of already used cancer drugs by providing drug delivery systems. Anticancer drugs can be encapsulated/attached with the nanomaterials and delivered at specific sites and cells under certain microenvironment conditions. Among metallic oxide nanoparticles, iron-based particles have shown great potential in drug delivery and at the same time for cancer treatment by producing localized heat. Therefore, researchers have focused on iron oxide nanoparticles as drug delivery vehicles. This chapter highlights the synthesizing methods of iron oxide nanoparticles such as co-precipitation, thermal decomposition, microemulsion, sol�gel, and additional chemical methods including hydrothermal, sonochemical decomposition, and electrochemical for their wide range of biomedical applications. It also provides a brief overview of recent developments in iron oxide nanoparticles, some limitations in the explored research areas. and suggests future directions to overcome these limitations. � 2021, Springer Nature Switzerland AG.en_US
dc.identifier.doi10.1007/978-3-030-79960-1_5
dc.identifier.issn23643293
dc.identifier.urihttp://10.2.3.109/handle/32116/3689
dc.identifier.urlhttps://link.springer.com/10.1007/978-3-030-79960-1_5
dc.language.isoen_USen_US
dc.publisherSpringer Science and Business Media Deutschland GmbHen_US
dc.subjectAntibodiesen_US
dc.subjectBiocompatibilityen_US
dc.subjectDrug deliveryen_US
dc.subjectIron oxide nanoparticlesen_US
dc.subjectSurface modificationen_US
dc.titlePotential of Iron Oxide Nanoparticles as Drug Delivery Vehicleen_US
dc.title.journalTopics in Mining, Metallurgy and Materials Engineeringen_US
dc.typeConference paperen_US
dc.type.accesstypeClosed Accessen_US

Files